Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

GW870086X

Known as: GW870086 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Acting on the glucocorticoid receptor (NR3C1), glucocorticoids are widely used to treat inflammatory diseases. However… 
2015
2015
Topical corticosteroids remain the first-line therapy for atopic dermatitis (AD). Hence, we investigated the efficacy and safety… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2015
Review
2015
Introduction: Inhaled corticosteroids are the only drugs that effectively suppress the airway inflammation, but they can induce… 
2015
2015
In this study, we demonstrated that GW870086X inhibited the bronchoconstrictor response to inhaledAMPchallenge after both a… 
  • figure 2
  • figure 1
  • figure 2
2013
2013
Glucocorticoids are highly effective therapies for a range of inflammatory diseases. Advances in the understanding of the diverse… 
2013
2013
PURPOSE Glucocorticoid (GC)-induced glaucoma is an undesirable side effect of traditional GCs. Ocular hypertension responsible… 
2013
2013
Abstract Objective: To assess the efficacy of inhaled, repeat doses (28 days) of the glucocorticoid agonist GW870086, which has…